○Yukina Miyagi^1,3, Akari Kouno¹, Saori Gocho^1,4,3, Yuka Miyachi¹, Chika Nakayama², Taeyuki Oshima¹ (1. College of Pharmacy, Kinjo Gakuin University, 2. Faculty of Pharmacy, Gifu University of Medical Science, 3. Graduate School of Medicine, Aichi Medical University, 4. Department of Pharmacy, Nagoya Ekisaikai Hospital)

○Issei Tamura¹, Wataru Imagawa¹, Hirotaka Osaki¹, Fumiki Shimada¹ (1. Santen Pharmaceutical Co., Ltd.)

○Masahide Kaneda¹, Tatsuro Yamamoto¹, Miki Shimada¹ (1. Dep. Pharm., Tottori Univ. Hosp.)

○Takehiro Kimura¹, Seitaro Fujishima², Naoko Hayashi^1,3, Hiroki Iwata^1,3, Noriko Kobayashi^1,3, Kazuko Fujimoto¹, Katsunori Yamaura^1,3 (1. Keio Univ Faculty Pharm, 2. Keio Univ School Med, 3. Keio Univ Commun Pharm)

○Wakana Suzuki¹, Yoshiaki Yamamoto^1,2, Shigeko Nishimura², Katsumi Imai², Yukitoshi Takahashi^1,2, Yasuharu Yazawa¹, Takashi Osawa¹, Yoshiyuki Kagawa¹ (1. Laboratory of Clinical Pharmaceutics, School of Pharmaceutical Sciences, University of Shizuoka, 2. NHO National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders )